Advances in epigenetic alterations of chronic lymphocytic leukemia: from pathogenesis to treatment
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Advances in epigenetic alterations of chronic lymphocytic leukemia: from pathogenesis to treatment ; volume:24 ; number:1 ; day:16 ; month:3 ; year:2024 ; pages:1-13 ; date:12.2024
Clinical and experimental medicine ; 24, Heft 1 (16.3.2024), 1-13, 12.2024
- Urheber
-
Zhang, Xin
Wang, Hua
Zhang, Ya
Wang, Xin
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s10238-023-01268-x
- URN
-
urn:nbn:de:101:1-2405210725266.758324647088
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 11:02 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Zhang, Xin
- Wang, Hua
- Zhang, Ya
- Wang, Xin
- SpringerLink (Online service)
Ähnliche Objekte (12)
Competing endogenous RNA networks related to prognosis in chronic lymphocytic leukemia: comprehensive analyses and construction of a novel risk score model
CTP synthase 2 predicts inferior survival and mediates DNA damage response via interacting with BRCA1 in chronic lymphocytic leukemia
Untersuchungen zur Antimalariawirkung von Chloroquin und von Inhibitoren des Glutathionmetabolismus
ENPP2 promotes progression and lipid accumulation via AMPK/SREBP1/FAS pathway in chronic lymphocytic leukemia
Recent progress of prognostic biomarkers and risk scoring systems in chronic lymphocytic leukemia
Targeting metabolic reprogramming in chronic lymphocytic leukemia
Multiple organs involved in the pathogenesis of non-alcoholic fatty liver disease
Serum neurofilament light chain: a novel biomarker for cardiovascular diseases in individuals without hypertension
Targeting the Wnt/β-catenin signaling pathway in cancer
EVI1 Disruption Post Neuroblastoma Treatment: A Case Analysis of Treatment-Associated Acute Myeloid Leukemia in a Pediatric Patient
Biomaterial‐Based In Situ Cancer Vaccines
Weighted inequalities for fractional integral operators and linear commutators in the Morrey-type spaces
Competing endogenous RNA networks related to prognosis in chronic lymphocytic leukemia: comprehensive analyses and construction of a novel risk score model
CTP synthase 2 predicts inferior survival and mediates DNA damage response via interacting with BRCA1 in chronic lymphocytic leukemia
Untersuchungen zur Antimalariawirkung von Chloroquin und von Inhibitoren des Glutathionmetabolismus
ENPP2 promotes progression and lipid accumulation via AMPK/SREBP1/FAS pathway in chronic lymphocytic leukemia
Recent progress of prognostic biomarkers and risk scoring systems in chronic lymphocytic leukemia
Targeting metabolic reprogramming in chronic lymphocytic leukemia
Multiple organs involved in the pathogenesis of non-alcoholic fatty liver disease
Serum neurofilament light chain: a novel biomarker for cardiovascular diseases in individuals without hypertension
Targeting the Wnt/β-catenin signaling pathway in cancer
EVI1 Disruption Post Neuroblastoma Treatment: A Case Analysis of Treatment-Associated Acute Myeloid Leukemia in a Pediatric Patient
Biomaterial‐Based In Situ Cancer Vaccines
Weighted inequalities for fractional integral operators and linear commutators in the Morrey-type spaces
Competing endogenous RNA networks related to prognosis in chronic lymphocytic leukemia: comprehensive analyses and construction of a novel risk score model
CTP synthase 2 predicts inferior survival and mediates DNA damage response via interacting with BRCA1 in chronic lymphocytic leukemia
Untersuchungen zur Antimalariawirkung von Chloroquin und von Inhibitoren des Glutathionmetabolismus
ENPP2 promotes progression and lipid accumulation via AMPK/SREBP1/FAS pathway in chronic lymphocytic leukemia
Recent progress of prognostic biomarkers and risk scoring systems in chronic lymphocytic leukemia
Targeting metabolic reprogramming in chronic lymphocytic leukemia
Multiple organs involved in the pathogenesis of non-alcoholic fatty liver disease
Serum neurofilament light chain: a novel biomarker for cardiovascular diseases in individuals without hypertension
Targeting the Wnt/β-catenin signaling pathway in cancer
EVI1 Disruption Post Neuroblastoma Treatment: A Case Analysis of Treatment-Associated Acute Myeloid Leukemia in a Pediatric Patient
Biomaterial‐Based In Situ Cancer Vaccines